GSA Capital Partners’s Asensus Surgical, Inc. ASXC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-225,538
Closed -$61K 2021
2023
Q3
$61K Sell
225,538
-675,670
-75% -$246K 0.01% 1411
2023
Q2
$455K Buy
901,208
+151,408
+20% +$90.5K 0.05% 806
2023
Q1
$493K Sell
749,800
-218,236
-23% -$148K 0.05% 729
2022
Q4
$336K Sell
968,036
-33,122
-3% -$13.5K 0.04% 860
2022
Q3
$449K Buy
1,001,158
+629,411
+169% +$328K 0.06% 651
2022
Q2
$148K Buy
371,747
+151,068
+68% +$67.4K 0.02% 1147
2022
Q1
$138K Buy
+220,679
New +$170K 0.02% 1247
2019
Q4
Sell
-1,032
Closed -$8K 1796
2019
Q3
$8K Buy
+1,032
New +$14K ﹤0.01% 1349
2018
Q1
Sell
-42,826
Closed -$1.07M 1868
2017
Q4
$1.07M Buy
+42,826
New +$1.32M 0.07% 558

Other funds holding ASXC

GSA Capital Partners's ASXC Position: Q4 2023 in Review

GSA Capital Partners sold out of Asensus Surgical, Inc. (ASXC) in Q4 2023, closing a stake of 225,538 shares — an estimated $61K sold.

GSA Capital Partners first reported a position in ASXC in Q4 2017 and held it in 9 quarters. The position peaked at $1.07M in Q4 2017. 73 funds tracked by Wall St. Rank hold ASXC as of Q4 2023.

  • GSA Capital Partners reported no remaining Asensus Surgical, Inc. position as of Q4 2023 after selling out during the quarter.
  • GSA Capital Partners sold 225,538 Asensus Surgical, Inc. shares in Q4 2023, an estimated $61K.
  • GSA Capital Partners first reported a position in Asensus Surgical, Inc. in Q4 2017 and held it in 9 quarters.
  • GSA Capital Partners's Asensus Surgical, Inc. position peaked at $1.07M in Q4 2017.
  • 73 funds tracked by Wall St. Rank held Asensus Surgical, Inc. as of Q4 2023.

Based on GSA Capital Partners's 13F filing for Q4 2023, filed 16 Feb 2024.